Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5690
|
pubmed:dateCreated |
1979-2-26
|
pubmed:keyword | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
E
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
276
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
744
|
pubmed:dateRevised |
2003-3-17
|
pubmed:meshHeading |
pubmed-meshheading:723950-Advisory Committees,
pubmed-meshheading:723950-DNA, Recombinant,
pubmed-meshheading:723950-Federal Government,
pubmed-meshheading:723950-Government Regulation,
pubmed-meshheading:723950-National Institutes of Health (U.S.),
pubmed-meshheading:723950-United States,
pubmed-meshheading:723950-United States Dept. of Health and Human Services
|
pubmed:articleTitle |
US extends recombinant DNA controls to private industry.
|
pubmed:publicationType |
News
|